0

Anti-inflammatory Therapeutic Market is Expected to Reach $125.5 Billion by 2028-Allied Market Research

 
2022
Anti-inflammatory Therapeutic Market

Report Code : A00196

quote Increase in the consumption of anti-inflammatory drugs for treating autoimmune inflammatory diseases. with lesser side effects compared to conventional drugs is anticipated to boost he market growth In addition, increase in uptake of corticosteroids for treating chronic obstructive pulmonary diseases (COPDs) and asthma coupled with rise in prevalence of atopic dermatitis is likely to propel, the growth of the anti-inflammatory therapeutics market. quote

Onkar Sumant
Manager, Healthcare at Allied Market Research

Get 20% Free Customization In This Report
Follow us on Social Media:       
 

According to a new report published by Allied Market Research, titled, Anti-Inflammatory Therapeutics Market, by Drug Class and Indication Type : Global Opportunity Analysis and Industry Forecast, 2021-2028,” the global anti-inflammatory therapeutics market size was $98,026 million in 2020 and is projected to reach $125,552 million by 2028, registering a CAGR of 4.0% from 2021 to 2028.

Anti-inflammatory therapeutics help in easing acute and chronic pain, including migraines & headaches, rheumatic arthritis, sprains, or even menstrual pain. These therapeutics provide faster relief as compared to other drugs. Moreover, they are capable of lowering the levels of prostaglandins and the chemicals responsible for inflammation as well as reducing pain and swelling.

The key factors driving the growth of the global anti-inflammatory market include alarming increase in prevalence of autoimmune & respiratory conditions, new drugs in pipeline, and surge adoption of anti-inflammatory drugs. Furthermore, the demand for anti-inflammatory drugs has been increasing notably, owing to the emergence of anti-inflammatory biologics that are more targeted, effective, and with lesser side effects as compared to conventional drugs. Moreover, rise in awareness of anti-inflammatory therapeutics and attractive government initiatives toward the use of nonsteroidal anti-inflammatory drugs  in the Asia-Pacific and LAMEA are expected to augment the market growth during the analysis period. However, side effects of anti-inflammatory drugs and patent expiry issues of blockbuster drugs (such as Remicade) are known to impede the anti-inflammatory therapeutics market growth.

The impact of COVID-19 pandemic is expected to remain positive for the anti-inflammatory therapeutic market, owing to the inflammation caused by SARS-COV 2. SARS-CoV-2 is a beta coronavirus causing severe anti-inflammatory pneumonia, as COVID-19 can cause severe inflammation to patients diagnosed with it. According to reports, cytokine storm is strongly responsible for death in such patients. Some of the consequences of severe inflammation and cytokine storms include acute respiratory distress syndrome, acute lung injury, and multiple organ dysfunction syndromes, which lead to increase in the research and the development of anti-inflammatory drugs for the treatment of inflammation caused by COVID-19. For example, many clinical trials are currently underway to alleviate this destructive inflammation. One of them is NLRP3 inflammasome, which targets multiple mechanisms associated with COVID-19 excessive inflammation. Thus, such factors have positively impacted the market growth during the global health crisis.

The global anti-inflammatory therapeutics market is segmented into indication, drug class, and region. On the basis of indication, the market is categorized into arthritis, respiratory diseases, multiple sclerosis, psoriasis, anti-inflammatory bowel disease (IBD), and other anti-inflammatory diseases. Arthritis is expected to register the highest CAGR during the forecast period, owing to increase in geriatric population, as it is found to be more prevalent in the geriatric population and cause inflammation in joints.

Depending on drug class, it is fragmented into nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and biologics. The nonsteroidal anti-inflammatory drugs (NSAIDs) is expected to register the highest CAGR during the forecast period, owing to increase in patient population suffering from chronic disease and unavailability of effective treatments. Moreover, increase in affordability coupled with high healthcare spending and rise in awareness of biologics, especially, in emerging markets are expected to represent a huge market potential for biologics. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

North America accounted for the largest market share in 2020, and is anticipated to maintain its dominance from 2020 to 2028, due to high expenditure on R&D, presence of major players & their product availability, and well-established healthcare infrastructure in the region. However, Asia-Pacific is expected to register the highest CAGR during the forecast period, as governments of Asian countries are investing in the development of healthcare infrastructure.

Some of the key players operating in the anti-Inflammatory Therapeutic market are Pfizer, Inc., Abbvie, Inc., Johnson & Johnson, GlaxoSmithKline, Merck & CO., Inc., Novartis, F. Hoffman, La Roche AG, Eli Lily and Company, AstraZeneca PLC., and Amgen..

Key Findings Of The Study

  • North America occupied 36.64% share of the global anti-inflammatory therapeutic market in 2020.
  • By indication, the arthritis segment is anticipated to grow with the highest CAGR throughout the forecast period.
  • By indication, the arthritis segment was the highest contributor to the anti-inflammatory therapeutics market, with $39,481.09 million in 2020, and is estimated to reach $52,952.43 million by 2028, at a CAGR of 4.6% during the forecast period.
  • Depending on drug class, the anti-inflammatory biologics segment accounted for $58,618.54 million in 2020, and is estimated to reach $77,093.85 million by 2028, registering a CAGR of 4.3%.
  • Asia-Pacific is estimated to grow at the highest CAGR of 5.2% during the forecast period.
 

Need More Information

pr-det-talk Talk to David (Europe)

pr-det-talk Talk to Sona Padman (Americas)

5933 NE Win Sivers Drive #205,
Portland, OR 97220 United States

pr-det-phone Toll Free: +1-800-792-5285

pr-det-phone UK: +44-845-528-1300

pr-det-phone Hong Kong: +852-301-84916

pr-det-phone India (Pune): +91 2066346060

pr-det-phone Fax: +1(855) 550-5975

pr-det-phone help@alliedmarketresearch.com

 

For Media Inquiries, Please Contact

Allied Market Research
Contact Toll Free: +1-800-792-5285
Drop us an email at
media@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Free Sample
 
 

First time buyer?
Check offers and discount on this report
To get this report

Click Here
 
 

quote Anti-Inflammatory Therapeutics Market by Drug Class (Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids, and Biologics), Indication Type (Arthritis, Respiratory Diseases, Multiple Sclerosis, Psoriasis, Anti-inflammatory Bowel Disease (IBD), and Other Anti-inflammatory Diseases): Global Opportunity Analysis and Industry Forecast, 2021–2028 quote

View Report
 
 

Avenue: Entire Library membership of Allied Market Research Reports at your disposal

  • Avenue is an innovative subscription-based online report database.
  • Avail an online access to the entire library of syndicated reports on more than 2,000 niche industries and company profiles on more than 12,000 firms across 11 domains.
  • A cost-effective model tailored for entrepreneurs, investors, and students & researchers at universities.
  • Request customizations, suggest new reports, and avail analyst support as per your requirements.
  • Get an access to the library of reports at any time from any device and anywhere.

 
 

WHY ALLIED MARKET RESEARCH?

INFLALLIBLE METHODOLOGY

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

ANALYST SUPPORT

For complete satisfaction

CUSTOMIZATION

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 

Featured Readings

 

Buy Full Version
"Anti-inflammatory Therapeutic Market"
Purchase Enquiry

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of the scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save the time of readers